Phase I-II Study of Vinblastine in Combination With Nilotinib in Children, Adolescents, and Young Adults With Refractory or Recurrent Low-Grade Glioma
Phase of Trial: Phase II
Latest Information Update: 05 Oct 2017
At a glance
- Drugs Nilotinib (Primary) ; Vinblastine
- Indications Glioma
- Focus Therapeutic Use
- Acronyms VINILO
- Sponsors Novartis
- 11 Jul 2016 Planned End Date changed from 1 May 2019 to 1 Dec 2020.
- 11 Jul 2016 Planned primary completion date changed from 1 May 2017 to 1 Dec 2018.
- 07 Jun 2016 Interim results (n=35) presented at the 52nd Annual Meeting of the American Society of Clinical Oncology